Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.
Preda CM, Popescu CP, Baicus C, Voiosu TA, Manuc M, Pop CS, Gheorghe L, Sporea I, Trifan A, Tantau M, Tantau A, Ceausu E, Proca D, Constantinescu I, Ruta SM, Diculescu MM, Oproiu A.
Preda CM, et al. Among authors: sporea i.
Liver Int. 2018 Apr;38(4):602-610. doi: 10.1111/liv.13550. Epub 2017 Sep 5.
Liver Int. 2018.
PMID: 28816020